You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動 | 方盛製藥(603998.SH)漲停 引入戰投德維特公司
格隆匯 05-25 09:40
格隆匯5月25日丨方盛製藥(603998.SH)漲停,報7.21元,成交額放大至8967萬元,總市值31億元。方盛製藥24日晚間公吿,公司控股子公司湖南省佰駿醫療擬引入腎科領域保健服務提供商DaVita Inc.之間接控股子公司DaVita China Pte Ltd.(簡稱“德維特公司”)為戰略投資者。值得一提的是,德維特公司控股股東DavitaInc是一家全球性公司,其單一大股東為巴菲特執掌的伯克希爾-哈撒韋公司。公司表示,Davita Inc作為全球領先的腎科領域保健服務提供商,戰略入股佰駿醫療後,將為其在腎病治療及健康管理等方面帶來先進的管理理念和技術,有利於提升其綜合競爭實力。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account